Report copyright - (NEO-)ADJUVANT THERAPY FOR HER-2+ BREAST CANCER · chemotherapy in this group. However, in small, node-negative tumours, combination of single-agent paclitaxel and trastuzumab provides
Please pass captcha verification before submit form